Reducing length of stay after transfemoral transcatheter aortic valve implantation: the FAST-TAVI II trial.
Eric DurandDelphine Beziau-GasnierMorgane MichelBernard IungDidier TchetcheGuillaume BonnetThibault LhermusierMartine GilardGeraud SouteyrandClaire BouletiPatrick OhlmannThierry LefevreFarzin BeyguiStephan ChassaingKarine ChevreulHélène Eltchaninoffnull nullnull nullPublished in: European heart journal (2024)
The intervention was simple and fast to implement, and was effective and safe to reduce LOS and increase the proportion of patients discharged early after TAVI (NCT04503655).
Keyphrases
- transcatheter aortic valve implantation
- aortic stenosis
- aortic valve replacement
- aortic valve
- ejection fraction
- transcatheter aortic valve replacement
- end stage renal disease
- randomized controlled trial
- newly diagnosed
- chronic kidney disease
- prognostic factors
- left ventricular
- peritoneal dialysis
- clinical trial
- study protocol
- heart failure
- phase iii
- open label